Journal article
A phase II multicenter study of stereotactic radiotherapy (SRT) for oligoprogression in metastatic renal cell cancer (mRCC) patients receiving tyrosine kinase inhibitor (TKI) therapy.
Abstract
5065
Authors
Cheung P; Patel S; North SA; Sahgal A; Chu W; Soliman H; Ahmad B; Winquist E; Patenaude F; Niazi T
Journal
Journal of Clinical Oncology, Vol. 38, No. 15_suppl, pp. 5065–5065
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
May 20, 2020
DOI
10.1200/jco.2020.38.15_suppl.5065
ISSN
0732-183X